Oct. 10, 2012 | Vol. 29 No. 20
FDA Lays Out Initial DMF Assessment Requirements Under GDUFA
The FDA has outlined the requirements that drugmakers submitting Type II active pharmaceutical ingredient (API) drug master files (DMF) must meet before the files are listed on the agency’s public website as available for reference to support an ANDA.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.